Experimental Ebola Serum Used On US Patient
|It appears I was correct, Dr Brantly, who did not get the
serum, did get the blood from a 14 yr old survivor of Ebola.
Mrs Writebol got the serum.
It sounds like the CDC is planning on continuing the experiment here in Georgia with the help of Franklin Graham. Samaritan's Purse relief organization is bringing 60 workers from Africa to all parts of the globe.
The countries of origin are not being mentioned to prevent an ourcry from the various populations.
Experimental Ebola Serum Used on U.S. Patient
A dose of “experimental serum” arrived in Liberia to be tried on a U.S. charity worker struggling for her life — but there was only enough for one of the two infected workers, so Dr. Kent Brantly asked that it be used on his colleague, the group Samaritan’s Purse said Thursday.
Dr. Brantly, a doctor with the group who was also infected, tried an alternative treatment, using blood transfused from a young survivor of the virus.
“Yesterday, an experimental serum arrived in the country, but there was only enough for one person. Dr. Brantly asked that it be given to Nancy Writebol,” Franklin Graham, president of Samaritan’s Purse, said in a statement. “However, Dr. Brantly received a unit of blood from a 14-year-old boy who had survived Ebola because of Dr. Brantly’s care. The young boy and his family wanted to be able to help the doctor that saved his life.”
CDC Issues Highest-Level Travel Warning as Ebola Spreads
Nancy Writebol's son, Jeremy, told NBC News he strongly commended Dr. Brantly's selflessness.
“Dr. Brantly has demonstrated once again how Jesus sacrificed for us," he said. "We pray for Kent’s full recovery and healing.”
The group didn’t say which drug had been shipped. There are several in development, including one that a Canadian company had been testing in people already but had stopped while it addressed U.S. Food and Drug Administration concerns.
"There was only enough for one person. Dr. Brantly asked that it be given to Nancy Writebol.”
"All we know and can say it is an experimental drug among several options that was the most promising," said Bruce Johnson, president of Serving in Mission USA. "Doctors on the ground in Liberia with Samaritan’s Purse and SIM were involved in the decision-to-use process, along with the consent of the patients."
Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, said he also had no idea which treatment the group may be using.
"The sad fact is we don't have any proven treatment for Ebola. We don't have any proven vaccine against Ebola," he told NBC News.
Companies may provide experimental drugs for use on a compassionate basis in cases of dire need. In this case, U.S. regulators may not need to become involved because the patients are not in the United States.
Some of the drugs are based on antibodies that are produced naturally by the body during infection. In some infections, antibodies from a survivor can help a patient fight infection. But Thomas Geisbert of the University of Texas Medical Branch, who is working to develop both drugs and vaccines for Ebola, said that is not a tried-and-true approach.
"It is a very controversial topic if you are talking about the serum from a survivor," Geisbert said. His team tried it in monkeys and it did not help them.
"This was something that was done on the past for infectious disease," Frieden said. "There are so many things we don’t know about why somebody may recover and which antibodies might be effective."
Support Free And Honest
Journalism At Rense.com
Enormous Online Archives,
MP3s, Streaming Audio Files,
Highest Quality Live Programs